Advice

in the absence of a submission from the holder of the marketing authorisation

paliperidone (Invega®) is not recommended for use within NHS Scotland.

Indication under review: For the treatment of psychotic or manic symptoms of schizoaffective disorder. Effect on depressive symptoms has not been demonstrated.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice68KB (PDF)

Download

Medicine details

Medicine name:
paliperidone (INVEGA)
SMC ID:
702/11
Indication:
For the treatment of psychotic or manic symptoms of schizoaffective disorder. Effect on depressive symptoms has not been demonstrated.
Pharmaceutical company
Janssen-Cilag Ltd
BNF chapter
Central nervous system
Submission type
Non submission
Status
Not recommended
Date advice published:
11 April 2011